Morgan Stanley Eloxx Pharmaceuticals, Inc. Transaction History

Morgan Stanley

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.15 - $7.2 $0 - $28	-4 Reduced 0.13%	3,176 $1,000
Q2 2022 Oct 27, 2022	SELL	$0.24 - $0.58 $588 - $1,422	-2,452 Reduced 43.54%	3,180 $1,000
Q2 2022 Aug 15, 2022	SELL	$0.24 - $0.58 $588 - $1,422	-2,452 Reduced 43.54%	3,180 $1,000
Q1 2022 Oct 27, 2022	BUY	$0.4 - $0.72 $980 - $1,765	2,452 Added 77.11%	5,632 $3,000
Q1 2022 May 13, 2022	BUY	$0.4 - $0.72 $776 - $1,397	1,941 Added 52.59%	5,632 $3,000
Q4 2021 Feb 14, 2022	BUY	$0.62 - $1.61 $1,796 - $4,665	2,898 Added 365.45%	3,691 $2,000
Q3 2021 Nov 15, 2021	BUY	$1.22 - $2.0 $967 - $1,586	793 New	793 $1,000

Ticker ELOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,656,200
Description
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.